Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing

导出原文传递

翻译打印收藏纠错

作者： Ngoune, Romeo ^[1] ; Contini, Christine ^[2] ; Hoffmann, Michael M. ; von Elverfeldt, Dominik ; Winkler, Karl ; Puetz, Gerhard

作者单位： Univ Freiburg, Fac Med, Dept Diagnost Radiol Med Phys, Med Ctr, Freiburg, Germany ^[1] Univ Freiburg, Fac Med, Inst Clin Chem & Lab Med, Med Ctr, Freiburg, Germany ^[2]

关键词 Cancer therapy EPR-effect liposomes pegylated liposomal doxorubicin toxicity adverse events plasmapheresis

发布时间 2018-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Current drug delivery

2018年15卷9期

1261-1270页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing

Current drug delivery

相似文献

Current drug delivery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing

Current drug delivery

相似文献

Current drug delivery

相关期刊

检索历史清除